Barely Significant
← all excerpts

Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?

Blood Rev · 2024 · PMC11051645 · PMID 38493006

Europe PMCDOI
1
hedged sentence
0.2600
closest p · 5.2× alpha
0.2600
boldest claim

The sentences

showed a trendP = 0.26not close (p > 0.1)
Nonetheless, incidence of Grade 3 diarrhea showed a trend towards improvement (odds ratio [OR] 0.61, 95% CI 0.35; 1.07, P = 0.26).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.